A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma

Condition:   Asthma Interventions:   Drug: Albuterol eMDPI DS;   Drug: albuterol Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials